values logo 400 m

Please Note our site uses cookies

You only need to accept once and can find out how we use cookies by clicking the link - Learn more

I understand

“Research and development (R&D) plays an essential role in developing new treatments, devices and methods of managing disease and constantly strives to improve the effectiveness of existing treatment. However, the benefits of R&D extend well beyond this and it is well documented that research active organisations have improved clinical outcomes, attract and retain high quality staff and can capitalise on an additional income streams.”

Dr Celia Skinner – Chief medical officer, Basildon and Thurrock University Hospitals Trust, Mid-Essex Hospitals Trust and Southend University Hospital Trust.

 

Research and development is led by our associate director Ashley Solieri under the clinical direction of Dr Rajesh Aggarwal.

We deal with all aspects of clinical research and development, including NHS Permissions, setting up studies, ethic applications, commercial and non-commercial research (original researcher led and student work), grant funding, and innovation and intellectual property. With our partnerships we provide a comprehensive service.

R and D Achievements 2018 19

Providing high quality research can improve outcomes for patients; this is at the centre of what we do. Research is embedded in the care we provide at the Trust and we aim to offer every patient the opportunity to take part in research.

Our aim is to increase the number of studies we can offer to our patients, and to help them understand more about research and what it means to the NHS.

Our researchers lead and contribute to world class research which helps us to understand diseases better and develop new treatments for the benefit of patients and the NHS.

“Research and development (R&D) plays an essential role in developing new treatments, devices and methods of managing disease and constantly strives to improve the effectiveness of existing treatment. However, the benefits of R&D extend well beyond this and it is well documented that research active organisations have improved clinical outcomes, attract and retain high quality staff and can capitalise on an additional income streams.”

Dr Celia Skinner – Chief medical officer, Basildon and Thurrock University Hospitals Trust, Mid-Essex Hospitals Trust and Southend University Hospital Trust.

 

Research and development is led by our associate director Ashley Solieri under the clinical direction of Dr Rajesh Aggarwal.

We deal with all aspects of clinical research and development, including NHS Permissions, setting up studies, ethic applications, commercial and non-commercial research (original researcher led and student work), grant funding, and innovation and intellectual property. With our partnerships we provide a comprehensive service.

R and D Achievements 2018 19

Providing high quality research can improve outcomes for patients; this is at the centre of what we do. Research is embedded in the care we provide at the Trust and we aim to offer every patient the opportunity to take part in research.

Our aim is to increase the number of studies we can offer to our patients, and to help them understand more about research and what it means to the NHS.

Our researchers lead and contribute to world class research which helps us to understand diseases better and develop new treatments for the benefit of patients and the NHS.

Meet the team

Meet the team

Dr Rajesh AggarwalClinical director, research and development
Dr Rajesh Aggarwal
01268 524900 ext. 4092

Additional information
Consultant Cardiologist and Clinical Director of R&D providing strategic and clinical direction.

 

 

 

 

 

 

ashley solieriAssociate director, research and development
Ms Ashley Solieri
01268 394673

Additional information
Leading strategic and general management of  the Trust’s R&D profile and the R&D Department. Also the named accountable officer for research and commercial innovation activity and service evaluation.

 

 

 


 


carol alvesResearch quality facilitator
Carol Alves
01268 524900 ext 3599

Additional information
First point of contact for researcher led studies (including student studies); experienced in research design and ethics applications.

 

 

 


 

jean byrneSenior clinical trials practitioner
Jean Byrne
01268 524900 ext 8384

Additional information
First point of contact for all NIHR adopted studies, research nurse capacity and Good Clinical Practice (GCP) training.

 

 

 


 

raiji koothoorResearch governance
Raiji Koothoor
01268 524900 ext 4672

Additional information
Undertakes study feasibility; experienced in contracts, costing and budget negotiations.

 

 

 


 

Research officerJackie Colnet Web
Jackie Colnet
01268 394675

Additional information

General enquires, site file maintenance, close out and archiving

 

 

 

.

Performance

There is a national ambition to see a dramatic and sustained improvement in the performance of providers of NHS services in initiating and delivering clinical research. The aim is to increase the number of patients who have the opportunity to participate in research and to enhance the nation’s attractiveness as a host for research.

The Government’s Plan for Growth, announced the transformation of incentives at local level for efficiency in initiation and delivery of research.

Our Trust publishes clinical research outcomes against two public benchmarks:

  • Initiating research – the time R&D takes setting-up a research study; up to 70 days from the time we receive a valid research application to the time we recruit the first patient into that study

  • Delivering research – for commercial contract clinical studies hosted by us, the time we took to recruit our first patient to the study against our projected recruitment.

All performance documentation can be seen the Research and Development 'documents' section.

 

Our-partnerships

Research cannot operate in isolation and involves a great deal of collaboration to achieve optimal results. Our key collaborators are:

The National Institute for Health Research
The NIHRis funded through the Department of Health to improve the health and wealth of the nation through research.

The National Institute for Health Research, Clinical Research Network (CRN)
Funded via the NIHR, the Clinical Research Network (CRN) comprises of 15 local CRN that cover England. Each local CRN supports its member trust in delivering research studies. We are part of North Thames CRN (NT; CRN).

The Health Research Authority (HRA)
The HRA protects and promotes the interests of patients and the public in health research, and to streamline the regulation of research.
The HRA provide an ethical opinion on research conducted in the NHS.

Anglia Ruskin University (ARU)
ARU is one of the largest universities in the east of England. Our two partners within ARU are the School of Medicine  and Anglia Ruskin Clinical Trials Unit (ARCTU). Our Joint Cardiology Research Unit with ARU is supporting several Doctor of Medicine (MD) fellows, a PhD student and two senior research fellows. The Associate Director works closely with ARU is an Honorary Visiting Fellow of the School of Medicine and is the expert external member of the university’s Research Ethics Sub Committee.

News and events

2017

International Clinical Trials Day  Friday 19th May 2017

The R&D team are celebrating International Clinical Trials Day on Friday 19th May 2017 with the launch of their “consent to contact” initiative. The team will be in the main entrance to the hospital highlighting the work they do and celebrating the valuable contribution of the volunteers that take part in research.

Please visit the stand to find out more

 

2015

Dementia Research Challenge

Through the National Institute for Health Research (NIHR), £22 million of additional funding is going into twenty-one pioneering research projects.

TACIT Trial results

Rheumatoid arthritis (RA) is a common condition causing pain through inflammation of the joints with progressive joint damage leading to disability.

Tumour necrosis factor inhibitor (TNF) is an innovative biological new drug treatment for RA but is very expensive with the treatment needed indefinitely as it suppresses RA rather than cures it.

Due to their cost, current guidance for the use of TNF is to limit its use to patients who have not responded to treatment by two standard synthetic RA drugs.

Previous evidence had shown that the use of a combination of conventional synthetic anti-rheumatic drug treatments could be effective and offer an alternative approach to treating patients with very active RA. This approach could offer an effective treatment for patients at a lower cost, potentially making resources available to fund TNF drugs in areas where it is not currently offered.

The TACIT trial recruited 432 patients to compare TNF against a combination treatment of conventional anti-rheumatic drugs. A randomised total of 205 patients were treated with TNF drugs with the remaining patients receiving the combination drug treatment.

The trial found the combination synthetic drug treatment was no less effective than treatment with the more expensive biological TNF drugs.

Dr Gendi and research nurses at Basildon Hospital was one of the sites running this NIHR funded study.

2014

Diabetes research – September

Natasha Christmas with Ian Luder and Georgina Butt

 

 

Ian Luder, previous chairman of the Trust, (pictured with Research Nurse Natasha Christmas and Clinical Trials Practitioner Georgina Butt) has diabetes and is an enthusiastic volunteer and champion of the DARE research.

He said: “It is only by doing research that new treatments can be developed, so I am pleased to be able to apply my condition to help.”

 

2013

Dr Farooq Maniyar, Consultant Neurologist, won the Harold G. Wolff Lecture Award 2013, given by the American Headache Society for the most significant original research in headache medicine of the year.

R&D celebrate International Clinical Trials Day and ‘It’s OK to ask’ campaign – May

Clinical trial day



 

Ashley Solieri, Associate Director of Research and Annaliza Sevillano, Cardiology RN Nurse.

Research publications

For information on publications by staff at Basildon, download this pdf of publications produced in 2018:

Useful links

safeguardingVisit our safeguarding page

healthwatchClick here for Your one-stop-shop for information about health and care services in your area.

Contact us

  • Basildon and Thurrock University Hospitals NHS Foundation Trust
    Nethermayne, Basildon
    Essex  SS16 5NL
    Switchboard: 01268 524900

  • The Essex Cardiothoracic Centre
    Nethermayne, Basildon
    Essex SS16 5NL
    Switchboard: 01268 524900

How to find us

Click here for more information on how to get to our hospitals

We are a smoke-free Trust

Smoking is not allowed in any hospital building or grounds.

Smokefree Logo Navy background

Follow us

 

Tell us what you think

If you have recently attended our hospital or accompanied or visited a patient, you can complete our Friends and Family Test survey here:

See our Friends and Family Test page

Friends and family test - tell us what you think

 

 

Back to top